Feedback on the PRAC of December 2024 (25 – 28 November)

News Healthcare & Pharma Consultations

Date: 9th Dec, 2024 Source: French National Agency for the Safety of Medicines and Health Products (ANSM) Country: France Original Source

Brief

"On November 25-28, 2023, the PRAC reviewed available data on doxycycline use and risk of suicide. After examining all data from spontaneous reports, literature, potential mechanisms discussions, and an epidemiological study via DARWIN EU, the PRAC concluded that these data were not sufficient to establish a causal link." (Providing output without exceeding 90 words)

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Feedback on the PRAC of December 2024 (25 – 28 November)

Brief

French National Agency for the Safety of Medicines and Health Products (ANSM)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Feedback on the PRAC of December 2024 (25 – 28 November)

Brief

French National Agency for the Safety of Medicines and Health Products (ANSM)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.